Discontinued — last reported Q4 '20
Current Assets
Available-for-Sale Debt Securities - Amortized Cost
Merck & Co. Available-for-Sale Debt Securities - Amortized Cost decreased by 30.3% to $101.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 81.2%, from $536.00M to $101.00M. Over 5 years (FY 2020 to FY 2025), Available-for-Sale Debt Securities - Amortized Cost shows an upward trend with a 2.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ3 2015
Last reportedQ4 2020
How to read this metric
An increase reflects new debt security purchases, while a decrease indicates maturities or sales of existing holdings.
Detailed definition
This represents the original cost of debt securities classified as available-for-sale, adjusted for amortization of prem...
Peer comparison
Standard accounting metric; allows for comparison of investment cost bases across financial institutions.
Metric ID:
afs_debt_securities_amortized_costHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $88.00M | $89.00M | $86.00M | $454.00M | $412.00M | $76.00M | $569.00M | $760.00M | $821.00M | $247.00M | $337.00M | $117.00M | $127.00M | $81.00M | $536.00M | $690.00M | $707.00M | $145.00M | $101.00M |
| QoQ Change | — | +1.1% | -3.4% | +427.9% | -9.3% | -81.6% | +648.7% | +33.6% | +8.0% | -69.9% | +36.4% | -65.3% | +8.5% | -36.2% | +561.7% | +28.7% | +2.5% | -79.5% | -30.3% |
| YoY Change | — | — | — | — | +368.2% | -14.6% | +561.6% | +67.4% | +99.3% | +225.0% | -40.8% | -84.6% | -84.5% | -67.2% | +59.1% | +489.7% | +456.7% | +79.0% | -81.2% |
Range$76.00M – $821.00M
CAGR+3.1%
Avg YoY Growth+135.5%
Median YoY Growth+67.4%
Current Streak2 quarters decline
Available-for-Sale Debt Securities - Amortized Cost at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s available-for-sale debt securities - amortized cost?
- Merck & Co. (MRK) reported available-for-sale debt securities - amortized cost of $101.00M in Q4 2025.
- How has Merck & Co.'s available-for-sale debt securities - amortized cost changed year-over-year?
- Merck & Co.'s available-for-sale debt securities - amortized cost decreased by 81.2% year-over-year, from $536.00M to $101.00M.
- What is the long-term trend for Merck & Co.'s available-for-sale debt securities - amortized cost?
- Over 5 years (2020 to 2025), Merck & Co.'s available-for-sale debt securities - amortized cost has grown at a 2.6% compound annual growth rate (CAGR), from $89.00M to $101.00M.
- What does available-for-sale debt securities - amortized cost mean?
- The original purchase price of debt investments, adjusted for accounting adjustments, excluding current market price changes.